Hopp til hovedinnholdet

Publications

NIBIOs employees contribute to several hundred scientific articles and research reports every year. You can browse or search in our collection which contains references and links to these publications as well as other research and dissemination activities. The collection is continously updated with new and historical material.

2018

Sammendrag

Numerous species of wild berries are abundant in the Nordic forests, mountains and peat lands. They ripen throughout the early summer until late autumn. Both lingonberry (Vaccinium vitis-idaea) and bilberry (Vaccinium myrtillus), that are among the most picked wild berries, are characteristic field layer species in boreal forests. Other species that have potential of being better exploited are cloudberry (Rubus chamaemorus), crowberry (Empeterum nigrum), bog blueberry (Vaccinium uliginosum), arctic bramble (Rubus arcticus), wild strawberries/woodland strawberries (Fragaria vesca) and wild raspberries (Rubus idaeus). Wild berries have always been an important part of the Nordic cuisine. However, only about 5–10 per cent of the annual wild berry crop of approximately a billion kilograms are currently picked for private or commercial consumption. There are several challenges towards an increased utilization as year-to-year variation in crop, topography, logistics of berry picking including traceability, fragmented sector structure and the high share of unprocessed raw material in export. The scientific interest for these berries have in the recent years focused on their value concerning human health benefits. Nevertheless, commercialization and innovation of wild berries should focus on multiple use of the whole raw material into many different products. The Nordic wild berries are perfectly adapted to their environment and are well suited to studies of environmental effects on growth, development and quality. Additionally, they represent a valuable genepool for future breeding.

Til dokument

Sammendrag

Given the compound differences between tris(2-butoxyethyl)- and tris(2-cloroethyl) phosphate (TBOEP and TCEP, respectively), we hypothesized that exposure of juvenile salmon to TBOEP and TCEP will produce compound-specific differences in uptake and bioaccumulation patterns, resulting in potential formation of OHmetabolites. Juvenile salmon were exposed to waterborne TCEP or TBOEP (0.04, 0.2 and 1 mg/L) for 7 days. The muscle accumulation was measured and bioconcentration factor (BCF) was calculated, showing that TCEP was less accumulative and resistant to metabolism in salmon than TBOEP. Metabolite formations were only detected in TBOEP-exposed fish, showing seven phase I biotransformation metabolites with hydroxylation, ether cleavage or combination of both reactions as important metabolic pathways. In vitro incubation of trout S9 liver fraction with TBOEP was performed showing that the generated metabolite patterns were similar to those found in muscle tissue exposed in vivo. However, another OH-TBOEP isomer and an unidentified metabolite not present in in vivo exposure were observed with the trout S9 incubation. Overall, some of the observed metabolic products were similar to those in a previous in vitro report using human liver microsomes and some metabolites were identified for the first time in the present study. Toxicological analysis indicated that TBOEP produced less effect, although it was taken up faster and accumulated more in fish muscle than TCEP. TCEP produced more severe toxicological responses in multiple fish organs. However, liver biotransformation responses did not parallel the metabolite formation observed in TBOEP-exposed fish.